retatrutide 2025 trial results Retatrutide—A Game Changer in Obesity Pharmacotherapy October 27, 2025: U.K. regulators

Another study showed that GLP-1R knockout mice have impaired LTP when compared to control animals ( These previous studies together suggest that GLP-1 may improve memory and cognitive function in patients with depression by enhancing synaptic function and neuronal signal transmission in the brain

Clinical data suggests focusing on the 4-week mark for meaningful weight assessment rather than daily or weekly fluctuations early on

Aegis Peptides also supplies Bacteriostatic Water as a related laboratory product

These products, particularly when they are injected, can carry significant health risks, including contamination, infection, local tissue damage or potentially life-threatening reactions

Branded Saxenda sales fell to roughly $300 million in the first half of 2025 as newer GLP-1 therapies, including semaglutide and tirzepatide, gained market share

Meal Inspiration : Throw a handful into smoothies, salads, or scrambled eggs for an easy, nutritious boost